This document is an excerpt from the EUR-Lex website
Document 22014D0177
Decision of the EEA Joint Committee No 177/2014 of 25 September 2014 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2015/1245]
Decision of the EEA Joint Committee No 177/2014 of 25 September 2014 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2015/1245]
Decision of the EEA Joint Committee No 177/2014 of 25 September 2014 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2015/1245]
OJ L 202, 30.7.2015, p. 27–27
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
- Date of document:
- 25/09/2014; Date of adoption
- Date of effect:
- 26/09/2014; Entry into force See Art 3
- Date of end of validity:
- No end date
- Author:
- EEA Joint Committee
- Form:
- Decision adopted by bodies created by international agreements
- Internal comment:
- EEA Joint Committee
- Treaty:
- Agreement on the European Economic Area
- Legal basis:
-
- 21994A0103(01) - A98
- Link
- Link
- Link
- Select all documents mentioning this document No data available in the table
- Modifies:
-
Relation Act Comment Subdivision concerned From To Modifies 21994A0103(52) Addition chapter XIII point 13 indent 26/09/2014 - Instruments cited:
- Link
- EUROVOC descriptor:
- Subject matter:
- Directory code:
|
30.7.2015 |
EN |
Official Journal of the European Union |
L 202/27 |
DECISION OF THE EEA JOINT COMMITTEE
No 177/2014
of 25 September 2014
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2015/1245]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) No 19/2014 of 10 January 2014 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance chloroform (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Regulation (EU) No 20/2014 of 10 January 2014 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance butafosfan (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following indents are added in point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II to the EEA Agreement:
|
‘— |
32014 R 0019: Commission Implementing Regulation (EU) No 19/2014 of 10 January 2014 (OJ L 8, 11.1.2014, p. 18), |
|
— |
32014 R 0020: Commission Implementing Regulation (EU) No 20/2014 of 10 January 2014 (OJ L 8, 11.1.2014, p. 20).’ |
Article 2
The texts of Implementing Regulations (EU) No 19/2014 and (EU) No 20/2014 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 26 September 2014, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 25 September 2014.
For the EEA Joint Committee
The President
Kurt JÄGER
(*1) No constitutional requirements indicated.
